. 2013 Sep 26;19(3):173–181. doi: 10.1016/j.rpor.2013.08.007

Table 1.

Patient and tumor characteristics.

	n	%
Ethnicity (n = 363)
Caucasian	298	82
Asian	65	18

Age (n = 363)
Bellow 40	88	24
40–60	220	61
Above 60	55	15

Menopausal status (n = 363)
Premenopausal	221	61
Postmenopausal	142	39

Family history of cancer (n = 349)^a
Breast	75	21
Other gynecologic	14	4
Others	7	2

History of breast cancer (n = 344)^a
Positive	12	3
Negative	332	97

Smoking (n = 298)^a
Yes	23	8
No	275	92

Parity (n = 299)^a
More than 3	146	49

History of hormone therapy (n = 210)^a
Yes	92	44
No	118	56

Breast feeding (n = 208)^a
Yes	132	63
No	76	37

Laterality of breast cancer (n = 363)
Right	191	53
Left	169	46
Bilateral	3	1

Localization (n = 363)
UOQ	167	46
Multicentric	38	10

Histological type (n = 363)
IDC	291	80
ILC	13	4
Medullary	35	10
Mucinous and tubular	9	2
Others	12	4

Grade (n = 320)^a
I	33	10
II	105	33
III	182	57

T stage (n = 353)^a
T1	63	18
T2	156	44
T3	43	12
T4	91	26

N stage (n = 353)^a
N0	151	43
N1	85	24
N2	94	27
N3	23	6

Metastatic at diagnosis (n = 25)^b
Bone	15	60
Lung	10	40
Liver	8	32

Stage (n = 353)^a
I	49	14
II	148	42
III	131	37
IV	25	7

Ki67 (n = 198)^a
Positive	128	65
Negative	70	35

LVI (n = 315)^a
Present	90	29
Absent	225	71

DCIS (n = 301)
Present	77	26
Absent	224	74

Only available data in cohort cases could be analyzed.

Some patients were presented with two or more sites of metastasis.